4941 related articles for article (PubMed ID: 4043536)
1. Factors affecting the production of plasminogen activator in cultures of normal fibroblasts.
Kadouri A; Bohak Z
Dev Biol Stand; 1985; 60():431-7. PubMed ID: 4043536
[TBL] [Abstract][Full Text] [Related]
2. Regulation of plasminogen activator activity in human fibroblastic cells by fibrosarcoma cell-derived factors.
Saksela O; Laiho M; Keski-Oja J
Cancer Res; 1985 May; 45(5):2314-9. PubMed ID: 3921241
[TBL] [Abstract][Full Text] [Related]
3. Expression of serine proteinases and metalloproteinases in organ-cultured human skin. Altered levels in the presence of retinoic acid and possible relationship to retinoid-induced loss of epidermal cohesion.
Varani J; Burmeister B; Sitrin RG; Shollenberger SB; Inman DR; Fligiel SE; Gibbs DF; Johnson K
Am J Pathol; 1994 Sep; 145(3):561-73. PubMed ID: 8080040
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.
De Petro G; Copeta A; Barlati S
Exp Cell Res; 1994 Jul; 213(1):286-94. PubMed ID: 8020601
[TBL] [Abstract][Full Text] [Related]
5. Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.
Colucci M; Gesualdo L; Montemurro P; Cavallo LG; Conese M; Mascolo E; Ranieri E; Di Paolo S; Schena FP; Semeraro N
Thromb Haemost; 1995 Dec; 74(6):1516-20. PubMed ID: 8772230
[TBL] [Abstract][Full Text] [Related]
6. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
7. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
Diamond MP; Kruger M; Saed GM
Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
[TBL] [Abstract][Full Text] [Related]
10. The production and properties of a tissue plasminogen activator from normal epithelial cells grown in microcarrier culture.
Griffiths JB; McEntee ID; Electricwala A; Atkinson A; Sutton PM; Naish S; Riley PA
Dev Biol Stand; 1985; 60():439-46. PubMed ID: 3899799
[TBL] [Abstract][Full Text] [Related]
11. Human hepatoma cell line plasminogen activator.
Levin EG; Fair DS; Loskutoff DJ
J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of fibroblast growth factors on expression of genes of the plasminogen activator and insulin-like growth factor systems by human breast fibroblasts.
Sieuwerts AM; Martens JW; Dorssers LC; Klijn JG; Foekens JA
Thromb Haemost; 2002 Apr; 87(4):674-83. PubMed ID: 12008951
[TBL] [Abstract][Full Text] [Related]
13. Cultivation of Bowes melanoma cells in the Opticell system: influence of the addition of protein supplements to the serum-free medium on the production of plasminogen activator.
Bödeker BG; Klimetzek V; Klein U; Hewlett G; Schlumberger HD
Dev Biol Stand; 1987; 66():291-7. PubMed ID: 3108052
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator activity of rheumatoid and nonrheumatoid synovial fibroblasts.
Hamilton JA
J Rheumatol; 1982; 9(6):834-42. PubMed ID: 6891721
[TBL] [Abstract][Full Text] [Related]
15. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO
Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
[TBL] [Abstract][Full Text] [Related]
16. Organ-site dependence for the production of urokinase-type plasminogen activator and metastasis by human renal cell carcinoma cells.
Gohji K; Nakajima M; Boyd D; Dinney CP; Bucana CD; Kitazana S; Kamidono S; Fidler IJ
Am J Pathol; 1997 Dec; 151(6):1655-61. PubMed ID: 9403716
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of human synovial fibroblast plasminogen activator production by mononuclear cell supernatants.
Hamilton JA; Slywka J
J Immunol; 1981 Mar; 126(3):851-5. PubMed ID: 6161965
[TBL] [Abstract][Full Text] [Related]
18. Production of plasminogen activator in a melanoma cell line.
Matsuo O; Sakai T; Matsuo C; Nishida Y; Akazawa K; Mihara H
Acta Physiol Lat Am; 1983; 33(4):305-13. PubMed ID: 6377823
[TBL] [Abstract][Full Text] [Related]
19. Factors involved in the plasminogen activation system in human breast tumours.
Damjanovich L; Turzó C; Adány R
Thromb Haemost; 1994 Jun; 71(6):684-91. PubMed ID: 7974332
[TBL] [Abstract][Full Text] [Related]
20. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
